The World Health Organization galvanized global efforts to make clinical trials faster, more inclusive, and deeply rooted in …
The World Health Organization galvanized global efforts to make clinical trials faster, more inclusive, and deeply rooted in …
A key regulation is poised to reshape clinical research in Britain—reducing red tape, elevating patient voices and strengthening …
Clinical-stage companies AC Immune and Edgewise Therapeutics shared encouraging updates on their immunotherapy and cardiac medicine programs, signaling …
An established diagnostics firm gains critical funding to advance its wearable glucose monitoring technology and drive a strategic …
At ECCO 2025 in Berlin, Sanofi and Teva presented the first detailed findings from the RELIEVE UCCD study …
The FDA has cleared vimseltinib (Romvimza), a first-in-class CSF1R inhibitor, for symptomatic tenosynovial giant cell tumor—marking a breakthrough …
Parliament clears significant updates to the UK’s Clinical Trials Regulations—streamlining informed consent and laying the groundwork for improved …
New clinical-stage anti-obesity therapies began breaking ground—designed not just to shed pounds, but to retain muscle, offering a …
Parexel reveals strategic plans to ramp up its Indian operations—underscoring India’s emerging prominence as a critical node in …
Vertex Pharmaceuticals earns approval for JOURNAVX™ (suzetrigine), a ground-breaking oral NaV1.8 pain channel inhibitor designed to target moderate-to-severe …
Already a subscriber? Log in